Madrigal Pharmaceuticals
- Market cap
- 11.27B
- P/E (TTM)i
- -34.86
- P/Bi
- 21.52
- EPSi
- -12.85
- Div yieldi
- 0.00%
- 52W posi
- 43%
Anonymous reader poll. Unscientific, not investment advice.
Madrigal Pharmaceuticals shares were changing hands at 487.72, down 1.76% on the day. The company carries a market value of roughly 11.27B, the #1355 most valuable US-listed company we track. Across 12 analysts the consensus rating is Buy, with an average price target of 685.58 (+41%). Against a 52-week band of 393.61-615.00, the shares are currently 43% of the way up.
✦ StockVane Quant Insights how this is computed
- Below its 200-day average or in the bottom third on momentum — the strategy is out of it.
- Signal has read SELL for 1 week.
- Its last 6 Sell calls were actually followed by a +8% average gain three months out - this one has bounced back faster than the signal expected.
- Recent price momentum is +0.6% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 9.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 496.45
- Open
- 492.69
- Day range
- 486.77 - 502.34
- Avg price
- 493.16
- Volume
- 256.25K
- Turnover
- 126.37M
- Turnover ratei
- 1.87%
- Volume ratioi
- 0.96
- Amplitudei
- 3.14%
- 52-week rangei
- 393.61 - 615.00
Valuation
- P/Ei
- -37.95
- P/E (TTM)i
- -34.86
- P/Bi
- 21.52
- EPSi
- -12.85
- Book value / shi
- 22.67
- Net profit
- -296.89M
- Net assets
- 523.72M
Share structure
- Market cap
- 11.27B
- Float capi
- 6.69B
- Shares out
- 23.10M
- Float sharesi
- 13.72M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2016-07-25
20.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+13.41M net over the window
Short interest
- Shares short
- 2.25M
- % of floati
- 9.76%
- Days to coveri
- 11.42
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Madrigal Pharmaceuticals (MDGL)?
Madrigal Pharmaceuticals last traded at 487.72. The quote on this page refreshes every few seconds while US markets are open.
What is Madrigal Pharmaceuticals's market cap?
About 11.27B.
What is the P/E ratio of Madrigal Pharmaceuticals?
The trailing twelve-month P/E is -34.86. The Valuation tab shows it against the stock's own five-year range.
Does Madrigal Pharmaceuticals pay a dividend?
Madrigal Pharmaceuticals does not currently pay a regular dividend.
Is Madrigal Pharmaceuticals a buy according to analysts?
The consensus of 12 analysts is a Buy rating, with an average 12-month price target of 685.58, which implies 40.6% upside from the current price. This is not investment advice.
What is Madrigal Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Madrigal Pharmaceuticals a D (Sell). Below its 200-day average or in the bottom third on momentum — the strategy is out of it. Not investment advice.
Quote time 2026-10-08 07:10:38 · For reference only, not investment advice and not tailored to your situation.